MIM
LEGN icon

Monashee Investment Management’s Legend Biotech LEGN Stock Holding History

Monashee Investment Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Buy
+85,385
New +$2.3M 4.14% 10
2022
Q1 		– Sell
-30,000
Closed -$1.4M – 43
2021
Q4 		$1.4M Buy
+30,000
New +$1.52M 0.35% 35
2020
Q3 		– Sell
-50,000
Closed -$2.13M – 222
2020
Q2 		$2.13M Buy
+50,000
New +$1.95M 0.32% 94

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Monashee Investment Management's LEGN Position: Q2 2026 in Review

Monashee Investment Management opened a new position in Legend Biotech (LEGN) in Q2 2026: 85,385 shares worth $2.47M. The stake represents 4.14% of the portfolio and ranks #10 among its holdings. This is a return to the name: Monashee Investment Management previously reported a position in LEGN as recently as Q4 2021.

Monashee Investment Management first reported a position in LEGN in Q2 2020 and has held it in 3 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Monashee Investment Management held 85,385 shares of Legend Biotech worth $2.47M as of Q2 2026.
  • Legend Biotech was a new Monashee Investment Management position in Q2 2026.
  • Legend Biotech made up 4.14% of Monashee Investment Management's portfolio in Q2 2026, its #10 holding.
  • Monashee Investment Management first reported a position in Legend Biotech in Q2 2020 and has held it in 3 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Monashee Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.